News
Robert F. Kennedy Jr., an anti-vaxxer, has replaced the Centers for Disease Control and Prevention’ s Advisory Committee on Immunization Practices with his own cadre of people. --I.P., West Palm Beach ...
The International Human Frontier Science Program Organization (HFSPO) is pleased to award the 2026 HFSP Nakasone Award to ...
The U.S. Food and Drug Administration has granted full approval for Moderna's MRNA.O COVID-19 vaccine, Spikevax, in children aged 6 months through 11 years who are at an increased risk of the disease, ...
Shares of Moderna (NASDAQ:MRNA) have been long forgotten about since its demand for COVID shots fell off a cliff more than ...
The approval of Moderna's Spikevax for kids at higher risk of contracting the disease continues the company's regulatory ...
The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.
Technology can be harnessed to design novel and enhanced molecules that address challenges in biotechnology or medicine.
In an interview with The News & Observer, Dr. Barton Haynes talks future of HIV vaccine development after HHS canceled the ...
Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases. Promising results, but Phase ...
StockStory.org on MSN2d
Why Moderna (MRNA) Stock Is Up TodayWhat Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 3.8% in the morning session after the U.S. Food ...
In this episode presented by Eclipsebio, BioSpace's head of insights Lori Ellis discusses mRNA and srRNA with Andy Geall of ...
The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results